abstract |
Novel compounds according to general formula 1, wherein G1 is NR5R6 or a fused polycyclic group, which are specific agonists of the OT receptor and / or specific antagonists of the V1a receptor. Pharmaceutical compositions comprising these compounds are useful in the treatment, inter alia, of primary dysmenorrhea (see formula). |